ANI Pharmaceuticals EPS - Earnings per Share 2006-2021 | ANIP

ANI Pharmaceuticals eps - earnings per share from 2006 to 2021. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
ANI Pharmaceuticals Annual EPS
2020 $-1.88
2019 $0.50
2018 $1.30
2017 $-0.09
2016 $0.34
2015 $1.32
2014 $2.59
2013 $-0.92
2012 $0.00
2011 $-18.90
2010 $-25.26
2009 $-50.38
2008 $-23.03
2007 $-10.80
2006 $4.68
2005 $-17.99
ANI Pharmaceuticals Quarterly EPS
2021-03-31 $0.01
2020-12-31 $-0.30
2020-09-30 $0.04
2020-06-30 $-1.03
2020-03-31 $-0.59
2019-12-31 $-0.39
2019-09-30 $0.32
2019-06-30 $0.53
2019-03-31 $0.04
2018-12-31 $0.46
2018-09-30 $0.42
2018-06-30 $0.23
2018-03-31 $0.19
2017-12-31 $-0.82
2017-09-30 $0.40
2017-06-30 $0.23
2017-03-31 $0.10
2016-12-31 $-0.10
2016-09-30 $0.22
2016-06-30 $0.10
2016-03-31 $0.12
2015-12-31 $0.24
2015-09-30 $0.39
2015-06-30 $0.31
2015-03-31 $0.38
2014-12-31 $1.88
2014-09-30 $0.59
2014-06-30 $-0.21
2014-03-31 $0.33
2013-12-31 $4.98
2013-09-30 $0.13
2013-06-30 $-6.03
2013-03-31 $0.00
2012-12-31 $0.00
2012-09-30 $-1,295.10
2012-06-30 $-1,644.86
2012-03-31 $-3.18
2011-12-31 $-1.56
2011-09-30 $-4.38
2011-06-30 $-5.76
2011-03-31 $-7.20
2010-12-31 $-6.54
2010-09-30 $-5.76
2010-06-30 $-6.12
2010-03-31 $-6.84
2009-12-31 $-31.31
2009-09-30 $-7.56
2009-06-30 $-6.12
2009-03-31 $-5.40
2008-12-31 $-1.80
2008-09-30 $-8.64
2008-06-30 $-7.92
2008-03-31 $-4.68
2007-12-31 $-2.16
2007-09-30 $-2.16
2007-06-30 $-3.60
2007-03-31 $-2.88
2006-12-31 $15.83
2006-09-30 $-1.08
2006-06-30 $-3.96
2006-03-31 $-6.12
2005-12-31 $-4.68
2005-09-30 $-3.60
2005-06-30 $-4.68
2005-03-31 $-5.04
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.409B $0.208B
ANI Pharmaceuticals, Inc. is a specialty pharmaceutical company. It engaged in developing, manufacturing and marketing branded and generic prescription pharmaceuticals. The company offers liquid, powder, oral solid dose, cough/cold products, antacids, laxatives, stomach remedies as well as hydrocortisone retention enema, esterified estrogen and methyltestosterone, fluvoxamine maleate tablets, hydrocortisone rectal suspension, metoclopramide oral solution, opium tincture and metoclopramide tablets. In addition, it offers contract manufacturing services for other pharmaceutical companies. The company serves through wholesalers, smaller regional distributors and chains and pharmacy and retail outlets primarily in the United States. ANI Pharmaceuticals, Inc., formerly known as BioSante Pharmaceuticals, Inc., is headquartered in Baudette, MN.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $151.437B 10.08
Amgen (AMGN) United States $139.306B 15.03
Moderna (MRNA) United States $138.784B 276.51
CSL (CSLLY) Australia $98.426B 0.00
Gilead Sciences (GILD) United States $87.579B 8.46
BioNTech SE (BNTX) Germany $75.497B 54.74
Illumina (ILMN) United States $71.778B 103.50
Regeneron Pharmaceuticals (REGN) United States $62.129B 17.79
Vertex Pharmaceuticals (VRTX) United States $51.872B 20.20
Biogen (BIIB) United States $49.057B 13.47
Genmab (GNMSF) Denmark $29.343B 6.37
Genmab (GMAB) Denmark $29.308B 34.33
BeiGene (BGNE) Cayman Islands $28.840B 0.00
Seagen (SGEN) United States $26.668B 45.08
Horizon Therapeutics Public (HZNP) Ireland $23.064B 29.49
Alnylam Pharmaceuticals (ALNY) United States $21.373B 0.00
Bio-Rad Laboratories (BIO.B) United States $20.768B 44.27
Exact Sciences (EXAS) United States $19.243B 0.00
Bio-Techne Corp (TECH) United States $18.789B 98.80
Incyte (INCY) United States $17.022B 33.65
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $15.654B 0.00
ARGENX SE-ADR (ARGX) Netherlands $15.179B 0.00
BioMarin Pharmaceutical (BMRN) United States $14.347B 103.30
Novavax (NVAX) United States $13.633B 0.00
Repligen (RGEN) United States $13.232B 100.84
Zai Lab (ZLAB) China $12.892B 0.00
QIAGEN (QGEN) Netherlands $11.905B 20.16
Guardant Health (GH) United States $11.139B 0.00
CureVac (CVAC) Germany $9.693B 0.00
Intellia Therapeutics (NTLA) United States $9.338B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $9.017B 23.29
Mirati Therapeutics (MRTX) United States $8.223B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $8.208B 0.00
Fate Therapeutics (FATE) United States $8.091B 0.00
Acceleron Pharma (XLRN) United States $7.708B 0.00
Legend Biotech (LEGN) United States $6.354B 0.00
Ascendis Pharma (ASND) Denmark $6.293B 0.00
Denali Therapeutics (DNLI) United States $6.180B 221.70
SWEDISH ORP BIO (BIOVF) Sweden $6.024B 21.59
I-Mab (IMAB) China $5.857B 0.00
Halozyme Therapeutics (HALO) United States $5.848B 32.09
Twist Bioscience (TWST) United States $5.822B 0.00
Beam Therapeutics (BEAM) United States $5.655B 0.00
Sarepta Therapeutics (SRPT) United States $5.500B 0.00
Ultragenyx Pharmaceutical (RARE) United States $5.422B 0.00
NeoGenomics (NEO) United States $5.389B 914.00
Apellis Pharmaceuticals (APLS) United States $5.364B 0.00
Arvinas (ARVN) United States $5.284B 0.00
Exelixis (EXEL) United States $5.284B 84.30
Adaptive Biotechnologies (ADPT) United States $5.137B 0.00
Blueprint Medicines (BPMC) United States $4.944B 14.01
Vir Biotechnology (VIR) United States $4.732B 0.00
Reata Pharmaceuticals (RETA) United States $4.646B 0.00
SpringWorks Therapeutics (SWTX) United States $4.330B 0.00
AbCellera Biologics (ABCL) $4.232B 0.00
Certara (CERT) United States $4.193B 0.00
Alkermes (ALKS) Ireland $4.124B 121.71
Galapagos (GLPG) Belgium $3.967B 0.00
Arena Pharmaceuticals (ARNA) United States $3.784B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.570B 0.00
Emergent Biosolutions (EBS) United States $3.495B 8.45
Berkeley Lights (BLI) United States $3.107B 0.00
Intra-Cellular Therapies (ITCI) United States $2.858B 0.00
Dicerna Pharmaceuticals (DRNA) United States $2.857B 0.00
Editas Medicine (EDIT) United States $2.842B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $2.653B 0.00
Heska (HSKA) United States $2.629B 1146.50
Kymera Therapeutics (KYMR) United States $2.585B 0.00
Insmed (INSM) United States $2.540B 0.00
Sorrento Therapeutics (SRNE) United States $2.497B 0.00
Vericel (VCEL) United States $2.493B 672.13
Amicus Therapeutics (FOLD) United States $2.482B 0.00
Myriad Genetics (MYGN) United States $2.408B 0.00
ALX Oncology Holdings (ALXO) United States $2.392B 0.00
Arcus Biosciences (RCUS) United States $2.341B 0.00
Prothena (PRTA) Ireland $2.196B 0.00
Morphic Holding (MORF) United States $2.158B 0.00
Cytokinetics (CYTK) United States $2.106B 0.00
Revance Therapeutics (RVNC) United States $2.092B 0.00
Instil Bio (TIL) United States $2.087B 0.00
Protagonist Therapeutics (PTGX) United States $2.071B 0.00
Celldex Therapeutics (CLDX) United States $2.052B 0.00
Atea Pharmaceuticals (AVIR) United States $2.015B 0.00
Seer (SEER) $2.003B 0.00
Ligand Pharmaceuticals (LGND) United States $1.981B 29.01
Alector (ALEC) United States $1.920B 0.00
C4 Therapeutics (CCCC) United States $1.885B 0.00
MorphoSys AG (MOR) Germany $1.841B 0.00
Myovant Sciences (MYOV) United Kingdom $1.840B 0.00
Deciphera Pharmaceuticals (DCPH) United States $1.800B 0.00
Inovio Pharmaceuticals (INO) United States $1.780B 0.00
Global Blood Therapeutics (GBT) United States $1.739B 0.00
Bluebird Bio (BLUE) United States $1.731B 0.00
Castle Biosciences (CSTL) United States $1.717B 0.00
Bionano Genomics (BNGO) United States $1.698B 0.00
Amarin (AMRN) Ireland $1.674B 0.00
NGM Biopharmaceuticals (NGM) United States $1.642B 0.00
PHARMA MAR SA (PHMMF) Spain $1.628B 0.00
Avid Bioservices (CDMO) United States $1.594B 652.25
Zymeworks (ZYME) Canada $1.510B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.492B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.460B 0.00
Y-mAbs Therapeutics (YMAB) United States $1.460B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $1.440B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.432B 0.00
Sangamo Therapeutics (SGMO) United States $1.399B 0.00
REGENXBIO (RGNX) United States $1.384B 0.00
Codexis (CDXS) United States $1.376B 0.00
Nurix Therapeutics (NRIX) United States $1.368B 0.00
PureTech Health (PRTC) United States $1.366B 0.00
BioAtla (BCAB) United States $1.360B 0.00
MiMedx (MDXG) United States $1.354B 0.00
Ocugen (OCGN) United States $1.352B 0.00
UniQure (QURE) Netherlands $1.344B 4.57
Genetron Holdings (GTH) China $1.306B 0.00
Zealand Pharma (ZEAL) Denmark $1.269B 0.00
Repare Therapeutics (RPTX) Canada $1.230B 0.00
Inhibrx (INBX) United States $1.155B 0.00
Agenus (AGEN) United States $1.154B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.147B 0.00
Precigen (PGEN) United States $1.146B 0.00
Scholar Rock Holding (SRRK) United States $1.116B 0.00
Dynavax Technologies (DVAX) United States $1.087B 0.00
Nkarta (NKTX) United States $1.071B 0.00
MannKind (MNKD) United States $1.049B 0.00
Northwest Biotherapeutics (NWBO) United States $1.040B 0.00
Zealand Pharma (ZLDPF) Denmark $1.035B 0.00
Coherus BioSciences (CHRS) United States $0.995B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.993B 30.81
KaloBios Pharmaceuticals (HGEN) United States $0.980B 0.00
Shattuck Labs (STTK) United States $0.917B 0.00
Mesoblast (MESO) Australia $0.916B 0.00
Keros Therapeutics (KROS) United States $0.869B 0.00
Prometheus Biosciences (RXDX) United States $0.855B 0.00
Travere Therapeutics (TVTX) United States $0.837B 0.00
Pliant Therapeutics (PLRX) United States $0.831B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.816B 0.00
Sutro Biopharma (STRO) United States $0.810B 0.00
RAPT THERAPTICS (RAPT) United States $0.780B 0.00
Mersana Therapeutics (MRSN) United States $0.775B 0.00
IDEAYA Biosciences (IDYA) United States $0.773B 0.00
Avidity Biosciences (RNA) United States $0.755B 0.00
VBI Vaccines (VBIV) United States $0.752B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.751B 0.00
G1 THERAPEUTICS (GTHX) United States $0.731B 0.00
Pharming Group (PHAR) Netherlands $0.729B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.721B 0.00
Pharming Group (PHGUF) Netherlands $0.720B 23.00
Syndax Pharmaceuticals (SNDX) United States $0.713B 0.00
Curis (CRIS) United States $0.701B 0.00
Epizyme (EPZM) United States $0.689B 0.00
Merus (MRUS) Netherlands $0.674B 0.00
Adagene (ADAG) China $0.671B 0.00
Affimed (AFMD) Germany $0.671B 0.00
Kadmon Holdings (KDMN) United States $0.655B 0.00
Akoya Biosciences (AKYA) United States $0.653B 0.00
SESEN BIO, INC (SESN) United States $0.650B 0.00
Sinovac Biotech (SVA) China $0.642B 6.47
AnaptysBio (ANAB) United States $0.642B 0.00
Seres Therapeutics (MCRB) United States $0.641B 0.00
MeiraGTx Holdings (MGTX) United States $0.635B 0.00
Cara Therapeutics (CARA) United States $0.611B 53.04
ChromaDex (CDXC) United States $0.607B 0.00
Cellectis S.A (CLLS) France $0.604B 0.00
DBV Technologies S.A (DBVT) France $0.596B 0.00
Anika Therapeutics (ANIK) United States $0.592B 0.00
Intercept Pharmaceuticals (ICPT) United States $0.572B 0.00
Precision BioSciences (DTIL) United States $0.571B 0.00
Verastem (VSTM) United States $0.571B 0.00
ALBIREO PHARMA (ALBO) United States $0.563B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.561B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.548B 0.00
Brooklyn ImmunoTherapeutics (BTX) United States $0.518B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.517B 0.00
AC Immune SA (ACIU) Switzerland $0.517B 0.00
VistaGen Therapeutics (VTGN) United States $0.513B 0.00
Inventiva S.A (IVA) France $0.509B 0.00
Clovis Oncology (CLVS) United States $0.507B 0.00
Vaccitech (VACC) United Kingdom $0.507B 0.00
Clene (CLNN) United States $0.497B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.494B 0.00
XBiotech (XBIT) United States $0.488B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.485B 0.00
Compugen (CGEN) Israel $0.471B 0.00
Bolt Biotherapeutics (BOLT) United States $0.431B 0.00
Oncobiologics (OTLK) United States $0.418B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.413B 0.00
Kindred Biosciences (KIN) United States $0.413B 0.00
Athenex (ATNX) United States $0.412B 0.00
Cybin (CLXPF) Canada $0.412B 0.00
Spero Therapeutics (SPRO) United States $0.407B 0.00
Selecta Biosciences (SELB) United States $0.406B 0.00
Forte Biosciences (FBRX) United States $0.405B 0.00
Starpharma Holdings (SPHRY) Australia $0.400B 0.00
Codiak BioSciences (CDAK) United States $0.392B 0.00
Geron (GERN) United States $0.392B 0.00
Amryt Pharma (AMYT) United Kingdom $0.382B 0.00
BeyondSpring (BYSI) United States $0.378B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.376B 0.00
BioDelivery Sciences (BDSI) United States $0.370B 15.04
XOMA (XOMA) United States $0.363B 169.53
CytomX Therapeutics (CTMX) United States $0.361B 0.00
Athersys (ATHX) United States $0.357B 0.00
AquaBounty Technologies (AQB) United States $0.356B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.353B 0.00
Gritstone Bio (GRTS) United States $0.350B 0.00
SQZ Biotechnologies (SQZ) United States $0.349B 0.00
Theratechnologies (THTX) Canada $0.336B 0.00
Cue Biopharma (CUE) United States $0.334B 0.00
Cel-Sci (CVM) United States $0.333B 0.00
Opthea (OPT) Australia $0.330B 0.00
UROGEN PHARMA (URGN) United States $0.324B 0.00
Angion Biomedica (ANGN) United States $0.323B 0.00
Puma Biotechnology (PBYI) United States $0.308B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.308B 0.00
Fortress Biotech (FBIO) United States $0.308B 0.00
Neoleukin Therapeutics (NLTX) United States $0.307B 0.00
Clearside Biomedical (CLSD) United States $0.300B 0.00
Syros Pharmaceuticals (SYRS) United States $0.293B 0.00
WAVE Life Sciences (WVE) Singapore $0.290B 0.00
Frequency Therapeutics (FREQ) United States $0.274B 0.00
IBio (IBIO) United States $0.272B 0.00
Talis Biomedical (TLIS) United States $0.267B 0.00
Arbutus Biopharma (ABUS) United States $0.266B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.263B 0.00
Innate Pharma S.A (IPHA) France $0.259B 0.00
Cerecor (CERC) United States $0.257B 0.00
Prima BioMed (IMMP) Australia $0.257B 0.00
OVID THERAPEUTC (OVID) United States $0.255B 2.51
Paratek Pharmaceuticals (PRTK) United States $0.254B 0.00
INmune Bio (INMB) United States $0.251B 0.00
Fulcrum Therapeutics (FULC) United States $0.244B 0.00
Kaleido Biosciences (KLDO) $0.242B 0.00
Kamada (KMDA) Israel $0.241B 16.42
Chiasma (CHMA) United States $0.240B 0.00
Cogent Biosciences (COGT) United States $0.240B 0.00
Adicet Bio (ACET) United States $0.238B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.238B 0.00
Adverum Biotechnologies (ADVM) United States $0.233B 0.00
Trevena (TRVN) United States $0.230B 0.00
CorMedix Inc (CRMD) United States $0.227B 0.00
Kala Pharmaceuticals (KALA) United States $0.226B 0.00
Bellus Health (BLU) Canada $0.224B 0.00
TELA Bio (TELA) United States $0.218B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.217B 0.00
OSMOTICA PHARM (OSMT) United States $0.213B 0.00
Checkpoint Therapeutics (CKPT) United States $0.211B 0.00
ADMA Biologics Inc (ADMA) United States $0.206B 0.00
HOOKIPA Pharma (HOOK) United States $0.204B 0.00
Cardiff Oncology (CRDF) United States $0.200B 0.00
NextCure (NXTC) United States $0.194B 0.00
Seelos Therapeutics (SEEL) United States $0.182B 0.00
Beyond Air (XAIR) United States $0.178B 0.00
Biofrontera AG (BFRA) Germany $0.178B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.177B 0.00
Aptinyx (APTX) United States $0.175B 0.00
GENFIT S.A (GNFT) France $0.171B 0.00
Nicox SA (NICXF) France $0.171B 0.00
POXEL SA FRANCE (PXXLF) France $0.170B 0.00
Strongbridge Biopharma (SBBP) United States $0.168B 0.00
Synlogic (SYBX) United States $0.168B 0.00
VolitionRX (VNRX) United States $0.167B 0.00
PHASEBIO PHARMA (PHAS) United States $0.163B 0.00
VTv Therapeutics (VTVT) United States $0.161B 0.00
Enzo Biochem (ENZ) United States $0.156B 46.00
Applied Genetic Technologies (AGTC) United States $0.156B 0.00
X4 Pharmaceuticals (XFOR) United States $0.149B 0.00
ObsEva SA (OBSV) Switzerland $0.149B 0.00
Purple Biotech (PPBT) Israel $0.145B 0.00
Antibe Therapeutics (ATBPF) Canada $0.143B 0.00
LogicBio Therapeutics (LOGC) United States $0.137B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.137B 0.00
Eton Pharmaceuticals (ETON) United States $0.135B 0.00
Viridian Therapeutics (VRDN) United States $0.135B 0.00
Galena Biopharma (SLS) United States $0.131B 0.00
Catalyst Biosciences (CBIO) United States $0.131B 0.00
Abeona Therapeutics (ABEO) United States $0.126B 0.00
Liquidia Technologies (LQDA) United States $0.124B 0.00
Entera Bio (ENTX) Israel $0.121B 0.00
Orgenesis (ORGS) United States $0.120B 246.00
Voyager Therapeutics (VYGR) United States $0.120B 3.10
Exicure (XCUR) United States $0.120B 0.00
Cyclerion Therapeutics (CYCN) United States $0.118B 0.00
Novogen (KZIA) Australia $0.117B 0.00
ABVC BioPharma (ABVC) United States $0.117B 0.00
Cocrystal Pharma (COCP) United States $0.117B 0.00
Palatin Technologies (PTN) United States $0.115B 0.00
Eyenovia (EYEN) United States $0.111B 0.00
Longeveron (LGVN) United States $0.110B 0.00
Erytech Pharma SA (ERYP) France $0.109B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.108B 0.00
Pluristem Therapeutics (PSTI) Israel $0.106B 0.00
F-star Therapeutics (FSTX) United Kingdom $0.105B 0.00
Vascular Biogenics (VBLT) Israel $0.103B 0.00
Celsion (CLSN) United States $0.101B 0.00
Aytu BioPharma (AYTU) United States $0.101B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.101B 0.00
Dyadic (DYAI) United States $0.099B 0.00
Yumanity Therapeutics (YMTX) United States $0.096B 0.00
Armata Pharmaceuticals (ARMP) United States $0.096B 0.00
Evofem Biosciences (EVFM) United States $0.091B 0.00
Liminal BioSciences (LMNL) Canada $0.088B 0.00
AEterna Zentaris (AEZS) United States $0.088B 0.00
ARAVIVE, INC (ARAV) United States $0.086B 0.00
Vyant Bio (VYNT) United States $0.086B 0.00
Leap Therapeutics (LPTX) United States $0.085B 0.00
Aptevo Therapeutics (APVO) United States $0.083B 0.00
Zosano Pharma (ZSAN) United States $0.081B 0.00
AIkido Pharma (AIKI) United States $0.079B 0.00
Stealth BioTherapeutics (MITO) Cayman Islands $0.079B 0.00
Adocia (ADOCY) France $0.077B 0.00
Emmaus Life Sciences (EMMA) United States $0.074B 0.00
ATyr Pharma (LIFE) United States $0.074B 0.00
Evogene (EVGN) Israel $0.073B 0.00
Cidara Therapeutics (CDTX) United States $0.071B 0.00
Vaccinex (VCNX) United States $0.071B 0.00
Protalix BioTherapeutics (PLX) Israel $0.071B 0.00
DiaMedica Therapeutics (DMAC) United States $0.068B 0.00
Cytocom (CBLI) United States $0.067B 0.00
Edesa Biotech (EDSA) Canada $0.065B 0.00
Celyad SA (CYAD) Belgium $0.064B 0.00
Lumos Pharma (LUMO) United States $0.061B 0.00
Alimera Sciences (ALIM) United States $0.060B 0.00
Advaxis (ADXS) United States $0.060B 0.00
Oncotelic Therapeutics (OTLC) United States $0.059B 0.00
TRACON Pharmaceuticals (TCON) United States $0.059B 0.00
BioCardia (BCDA) United States $0.057B 0.00
ARIDIS PHARMACT (ARDS) United States $0.056B 0.00
Organovo Holdings (ONVO) United States $0.055B 0.00
Cyclo Therapeutics (CYTH) United States $0.053B 0.00
Genetic Technologies (GENE) Australia $0.053B 0.00
Idera Pharmaceuticals (IDRA) United States $0.053B 0.00
Windtree Therapeutics (WINT) United States $0.050B 0.00
Pulmatrix (PULM) United States $0.048B 0.00
AnPac Bio-Medical Science (ANPC) China $0.047B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.047B 0.00
Happiness Biotech Group (HAPP) China $0.047B 0.00
Invo BioScience (INVO) United States $0.046B 0.00
Enveric Biosciences (ENVB) United States $0.042B 0.00
Soligenix (SNGX) United States $0.039B 0.00
Acorda Therapeutics (ACOR) United States $0.037B 0.90
Timber Pharmaceuticals (TMBR) United States $0.035B 0.00
Lexaria Bioscience (LEXX) Canada $0.034B 0.00
Vallon Pharmaceuticals (VLON) United States $0.031B 0.00
Prana Biotechnology (ATHE) Australia $0.031B 0.00
GeoVax Labs (GOVX) United States $0.029B 0.00
Benitec Biopharma (BNTC) United States $0.029B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.028B 0.00
ThermoGenesis Holdings (THMO) United States $0.028B 0.00
IMMURON (IMRN) Australia $0.028B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.027B 0.00
Titan Pharmaceuticals (TTNP) United States $0.023B 0.00
ZIVO Bioscience (ZIVO) United States $0.019B 0.00
Palisade Bio (PALI) United States $0.009B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.000B 0.00
ImmunityBio (IBRX) United States $0.000B 0.00
Immatics (IMTX) Germany $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00